Cost Savings
Across several decades, multiple studies have documented the health and cost benefits of identifying and treating pregnant women who are using substances. Screening with the 4Ps Plus© accompanied by the “I Am Concerned...” Brief Intervention saves money and saves lives.
Download and read the 4P’s Plus© Costs Analysis Case Study to learn more.
The 4Ps Plus© is a copyrighted instrument that requires a licensing fee. Licensing fees vary based on the number of women being screened. NTI Upstream offers optional data management and tracking, reporting, and analysis for an additional fee.
The licensing fee for the 4Ps Plus© includes an initial webinar training with Dr. Ira J. Chasnoff on the screen and brief intervention administration, in addition to follow-up technical assistance.
Ira J. Chasnoff, MD